Historique
Bulletin de Périodique
Drug Testing and Analysis , Vol.13, n°3 - March 2021
Paru le :
01/03/2021
Année
2021
Page(s) :
467-728
Langue(s) :
Anglais
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Note de contenu :
SELECTION :
- Preliminary data on the potential for unintentional antidoping rule violations by permitted cannabidiol (CBD) use. Mareck U., Fusshöller G., Geyer H., Huestis M.A., Scheiff A.B., Thevis M., p. 539-549.
- A validated method for the simultaneous quantification of cannabidiol, Delta9-tetrahydrocannabinol, and their metabolites in human plasma and application to plasma samples from an oral cannabidiol open-label trial. Kevin R.C., Vogel R., Doohan P., Berger M., Amminger G.P., McGregor I.S., p. 614-627.
- Shape matters: The application of activity-based in vitro bioassays and chiral profiling to the pharmacological evaluation of synthetic cannabinoid receptor agonists in drug-infused papers seized in prisons. Antonides L.H., Cannaert A., Norman C., NicDaeid N., Sutcliffe O.B., Stove C.P., et al., p. 628-643.
- Large-scale evaluation of ion mobility spectrometry for the rapid detection of synthetic cannabinoid receptor agonists in infused papers in prisons. Norman C., McKirdy B., Walker G., Dugard P., NicDaéid N., McKenzie C., p. 644-663.
- An infrared spectroscopic approach to characterise white powders, easily applicable in the context of drug checking, drug prevention and on-site analysis. Deconinck E., Aït-Kaci C., Raes A., Canfyn M., Bothy J.-L., Duchateau C., et al., p. 679-693.
- New qualitative analysis strategy for illicit drugs using Raman spectroscopy and characteristic peaks method. Liu C.-M., He H.-Y., Xu L., Hua Z.-D., p. 720-728.
- Preliminary data on the potential for unintentional antidoping rule violations by permitted cannabidiol (CBD) use. Mareck U., Fusshöller G., Geyer H., Huestis M.A., Scheiff A.B., Thevis M., p. 539-549.
- A validated method for the simultaneous quantification of cannabidiol, Delta9-tetrahydrocannabinol, and their metabolites in human plasma and application to plasma samples from an oral cannabidiol open-label trial. Kevin R.C., Vogel R., Doohan P., Berger M., Amminger G.P., McGregor I.S., p. 614-627.
- Shape matters: The application of activity-based in vitro bioassays and chiral profiling to the pharmacological evaluation of synthetic cannabinoid receptor agonists in drug-infused papers seized in prisons. Antonides L.H., Cannaert A., Norman C., NicDaeid N., Sutcliffe O.B., Stove C.P., et al., p. 628-643.
- Large-scale evaluation of ion mobility spectrometry for the rapid detection of synthetic cannabinoid receptor agonists in infused papers in prisons. Norman C., McKirdy B., Walker G., Dugard P., NicDaéid N., McKenzie C., p. 644-663.
- An infrared spectroscopic approach to characterise white powders, easily applicable in the context of drug checking, drug prevention and on-site analysis. Deconinck E., Aït-Kaci C., Raes A., Canfyn M., Bothy J.-L., Duchateau C., et al., p. 679-693.
- New qualitative analysis strategy for illicit drugs using Raman spectroscopy and characteristic peaks method. Liu C.-M., He H.-Y., Xu L., Hua Z.-D., p. 720-728.
Cote :
Abonnement